Who to call at Incyte Corporation, and when
Fundz watches for the moments Incyte Corporation starts buying, and tells you who to reach.
- An alert the day Incyte Corporation raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Incyte Corporation, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Incyte Corporation. With Fundz connected, it knows.
Incyte and Genmab Form Partnership to Explore New Treatment for KRAS G12D-Mutated Metastatic Colorectal Cancer.
Contract Type
partnership
WilmingtonBiotechnologyTherapeuticsPharmaceuticalBiopharmaDescription
Incyte has partnered with Genmab to evaluate INCB161734 in combination with petosemtamab and chemotherapy in treating metastatic colorectal cancer with KRAS G12D mutations. This collaboration aims to enhance treatment options for patients who face poor prognoses with this specific cancer type.
Quick answer
Incyte and Genmab Form Partnership to Explore New Treatment for KRAS G12D-Mutated Metastatic Colorectal Cancer. (October 24, 2026). Incyte Corporation is based in Wilmington, Delaware, United States.
- What agreement did Incyte Corporation announce on October 24, 2026?
- Incyte has partnered with Genmab to evaluate INCB161734 in combination with petosemtamab and chemotherapy in treating metastatic colorectal cancer with KRAS G12D mutations. This collaboration aims to enhance treatment options for patients who face poor prognoses with this specific cancer type.
- What does Incyte Corporation do?
- Incyte is a global biopharmaceutical company focused on advancing innovative medicines through deep scientific expertise and a patient-centered approach.
- Where is Incyte Corporation based?
- Incyte Corporation is based in Wilmington, Delaware, United States.
- Which similar companies announced agreements around the same time?
- Celltrion (October 26, 2026), AbbVie Inc. (November 3, 2026), Edesa Biotech (November 9, 2026) and YD Bio Limited (October 20, 2026) also announced agreements within 45 days of Incyte Corporation.
Source: Fundz verified event record.
Other recent agreements in Therapeutics and Pharmaceutical
Contracts and agreements at companies in the same sectors within 45 days, from Fundz verified event records.
- Celltrion Secures Exclusive Supply Agreement for Omlyclo and Aptozma with U.S. Healthcare Company to Expand Market Access. (October 26, 2026)
- AbbVie partners with McLaren Racing in a multiyear collaboration to promote liver health awareness through Formula 1. (November 3, 2026)
- Edesa Biotech Enters Collaboration and License Agreement with Kyorin Pharmaceutical (November 9, 2026)
- YD Bio and EG BioMed Form Partnership with JoiiUp to Launch AI Cancer Risk Assessment for Corporate Wellness. (October 20, 2026)
- DARPA Awards Up to $10.7 Million Contract to RxMP Therapeutics for Development of RMP-402. (October 20, 2026)
- Hansoh Pharma and Roche Expand Partnership with $15 Billion Agreement for ADC Programs. (October 19, 2026)
Related People
Agreement Insights
What this usually meansIncyte Corporation signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.